Debt-to-equity of Talis Biomedical Corp from 31 Mar 2022 to 30 Jun 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Talis Biomedical Corp quarterly Debt-to-equity in % history and change rate from 31 Mar 2022 to 30 Jun 2024.
  • Talis Biomedical Corp Debt-to-equity for the quarter ending 30 Jun 2024 was 40%, a 43% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Talis Biomedical Corp Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q2 2024 40% +12% +43% 30 Jun 2024
Q1 2024 34% +7.4% +28% 31 Mar 2024
Q4 2023 28% +4.5% +19% 31 Dec 2023
Q3 2023 28% +9.4% +49% 30 Sep 2023
Q2 2023 28% +11% +62% 30 Jun 2023
Q1 2023 27% +7.6% +40% 31 Mar 2023
Q4 2022 24% 31 Dec 2022
Q3 2022 19% 30 Sep 2022
Q2 2022 17% 30 Jun 2022
Q1 2022 19% 31 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.